Crutchfield Bradford 的 Form 4 申報
10x Genomics, Inc.（TXG），2021/8/16 申報
- 申報編號
- 0001209191-21-051618
- 申報時間
- 2021/8/16
- 交易日
- 2021/8/12
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 7 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $271.5 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Crutchfield BradfordCIK 0001246406 | 高階主管（商務長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/8/12 | Class A Common Stock | M行使選擇權取得 | +17,000 | $1.16 | +$19,720 | 60,606 | 直接 | |
| 2021/8/12 | Class A Common Stock | S賣出處分 | −2,100 | $157.19F2 | −$330,099 | 58,506 | 直接 | |
| 2021/8/12 | Class A Common Stock | S賣出處分 | −2,400 | $158.07F3 | −$379,368 | 56,106 | 直接 | |
| 2021/8/12 | Class A Common Stock | S賣出處分 | −3,213 | $159.13F4 | −$511,284.69 | 52,893 | 直接 | |
| 2021/8/12 | Class A Common Stock | S賣出處分 | −3,400 | $160.00F5 | −$544,000 | 49,493 | 直接 | |
| 2021/8/12 | Class A Common Stock | S賣出處分 | −5,087 | $161.28F6 | −$820,431.36 | 44,406 | 直接 | |
| 2021/8/12 | Class A Common Stock | S賣出處分 | −800 | $161.84F7 | −$129,472 | 43,606 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/8/12 | Class A Common Stock | M行使選擇權處分 | −17,000 | $0.00 | $0 | 494,000 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $156.61 to $157.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $157.66 to $158.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $158.66 to $159.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $159.64 to $160.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This transaction was executed in multiple trades at prices ranging from $160.62 to $161.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
This transaction was executed in multiple trades at prices ranging from $161.62 to $162.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。